|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen MF, Yang YH, Lai CH, Chen PC and Chen
WC: Outcome of patients with esophageal cancer: A nationwide
analysis. Ann Surg Oncol. 20:3023–3030. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003-2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar
|
|
4
|
Zeng H, Chen W, Zheng R, Zhang S, Ji JS,
Zou X, Xia C, Sun K, Yang Z, Li H, et al: Changing cancer survival
in China during 2003-15: A pooled analysis of 17 population-based
cancer registries. Lancet Glob Health. 6:e555–e567. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pennathur A, Farkas A, Krasinskas AM,
Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ and
Luketich JD: Esophagectomy for T1 esophageal cancer: Outcomes in
100 patients and implications for endoscopic therapy. Ann Thorac
Surg. 87:1048–1054. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rustgi A and El-Serag HB: Esophageal
carcinoma. N Engl J Med. 372:1472–1473. 2015.PubMed/NCBI
|
|
7
|
Diepenbruck M and Christofori G:
Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no,
maybe? Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heyer BS, Warsowe J, Solter D, Knowles BB
and Ackerman SL: New member of the Snf1/AMPK kinase family, Melk,
is expressed in the mouse egg and preimplantation embryo. Mol
Reprod Dev. 47:148–156. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakano I, Paucar AA, Bajpai R, Dougherty
JD, Zewail A, Kelly TK, Kim KJ, Ou J, Groszer M, Imura T, et al:
Maternal embryonic leucine zipper kinase (MELK) regulates
multipotent neural progenitor proliferation. J Cell Biol.
170:413–427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Begley M, Li Q, Huang HT, Lako A,
Eck MJ, Gray NS, Mitchison TJ, Cantley LC and Zhao JJ: Mitotic
MELK-eIF4B signaling controls protein synthesis and tumor cell
survival. Proc Natl Acad Sci USA. 113:9810–9815. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du T, Qu Y, Li J, Li H, Su L, Zhou Q, Yan
M, Li C, Zhu Z and Liu B: Maternal embryonic leucine zipper kinase
enhances gastric cancer progression via the FAK/Paxillin pathway.
Mol Cancer. 13:1002014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Janostiak R, Rauniyar N, Lam TT, Ou J, Zhu
LJ, Green MR and Wajapeyee N: MELK promotes melanoma growth by
stimulating the NF-κB pathway. Cell Rep. 21:2829–2841. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Lee YM, Baitsch L, Huang A, Xiang
Y, Tong H, Lako A, Von T, Choi C, Lim E, et al: MELK is an
oncogenic kinase essential for mitotic progression in basal-like
breast cancer cells. Elife. 3:e017632014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuner R, Falth M, Pressinotti NC, Brase
JC, Puig SB, Metzger J, Gade S, Schäfer G, Bartsch G, Steiner E, et
al: The maternal embryonic leucine zipper kinase (MELK) is
upregulated in high-grade prostate cancer. J Mol Med (Berl).
91:237–248. 2013. View Article : Google Scholar
|
|
15
|
Kig C, Beullens M, Beke L, Van Eynde A,
Linders JT, Brehmer D and Bollen M: Maternal embryonic leucine
zipper kinase (MELK) reduces replication stress in glioblastoma
cells. J Biol Chem. 292:127862017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu Q, Ge Q, Zhou Y, Yang B, Yang Q, Jiang
S, Jiang R, Ai Z, Zhang Z and Teng Y: MELK promotes endometrial
carcinoma progression via activating mTOR signaling pathway.
EBioMedicine. 51:1026092020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pitner MK, Taliaferro JM, Dalby KN and
Bartholomeusz C: MELK: A potential novel therapeutic target for
TNBC and other aggressive malignancies. Expert Opin Ther Targets.
21:849–859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guan S, Lu J, Zhao Y, Yu Y, Li H, Chen Z,
Shi Z, Liang H, Wang M, Guo K, et al: MELK is a novel therapeutic
target in high-risk neuroblastoma. Oncotarget. 9:2591–2602. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ikeda Y, Sato S, Yabuno A, Shintani D,
Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y
and Hasegawa K: High expression of maternal embryonic
leucine-zipper kinase (MELK) impacts clinical outcomes in patients
with ovarian cancer and its inhibition suppresses ovarian cancer
cells growth ex vivo. J Gynecol Oncol. 31:e932020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Sun Q, Sun Y, Zhang J, Yuan H, Pang
S, Qi X, Wang H, Zhang M, Zhang H, et al: MELK and EZH2 cooperate
to regulate medulloblastoma cancer stem-like cell proliferation and
differentiation. Mol Cancer Res. 15:1275–1286. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen S, Zhou Q, Guo Z, Wang Y, Wang L, Liu
X, Lu M, Ju L, Xiao Y and Wang X: Inhibition of MELK produces
potential anti-tumour effects in bladder cancer by inducing G1/S
cell cycle arrest via the ATM/CHK2/p53 pathway. J Cell Mol Med.
24:1804–1821. 2020. View Article : Google Scholar
|
|
22
|
Kohler RS, Kettelhack H,
Knipprath-Meszaros AM, Fedier A, Schoetzau A, Jacob F and
Heinzelmann-Schwarz V: MELK expression in ovarian cancer correlates
with poor outcome and its inhibition by OTSSP167 abrogates
proliferation and viability of ovarian cancer cells. Gynecol Oncol.
145:159–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen L, Wei Q, Bi S and Xie S: Maternal
embryonic leucine zipper kinase promotes tumor growth and
metastasis via stimulating FOXM1 signaling in esophageal squamous
cell carcinoma. Front Oncol. 10:102020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar
|
|
25
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar
|
|
26
|
Yamini B: NF-κB, mesenchymal
differentiation and glioblastoma. Cells. 7:1252018. View Article : Google Scholar
|
|
27
|
Zhang Q, Lenardo MJ and Baltimore D: 30
years of NF-κB: A blossoming of relevance to human pathobiology.
Cell. 168:37–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM and Haller DG: AJCC cancer staging manual. Springer; New
York, NY: pp. 91–98. 2002
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Hu N, Clifford RJ, Yang HH, Wang C,
Goldstein AM, Ding T, Taylor PR and Lee MP: Genome wide analysis of
DNA copy number neutral loss of heterozygosity (CNNLOH) and its
relation to gene expression in esophageal squamous cell carcinoma.
BMC Genomics. 11:5762010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su H, Hu N, Yang HH, Wang C, Takikita M,
Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, et al: Global
gene expression profiling and validation in esophageal squamous
cell carcinoma and its association with clinical phenotypes. Clin
Cancer Res. 17:2955–2966. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rickman DS, Millon R, De Reynies A, Thomas
E, Wasylyk C, Muller D, Abecassis J and Wasylyk B: Prediction of
future metastasis and molecular characterization of head and neck
squamous-cell carcinoma based on transcriptome and genome analysis
by microarrays. Oncogene. 27:6607–6622. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sarrio D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liberzon A, Birger C, Thorvaldsdottir H,
Ghandi M, Mesirov JP and Tamayo P: The molecular signatures
database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar
|
|
35
|
Shimada Y, Imamura M, Wagata T, Yamaguchi
N and Tobe T: Characterization of 21 newly established esophageal
cancer cell lines. Cancer. 69:277–284. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pires BR, Mencalha AL, Ferreira GM, de
Souza WF, Morgado-Díaz JA, Maia AM, Corrêa S and Abdelhay ESF:
NF-kappaB is involved in the regulation of EMT genes in breast
cancer cells. PLoS One. 12:e01696222017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
38
|
Li Y, Lu L, Tu J, Zhang J, Xiong T, Fan W,
Wang J, Li M, Chen Y, Steggerda J, et al: Reciprocal regulation
between forkhead box M1/NF-κB and methionine adenosyltransferase 1A
drives liver cancer. Hepatology. 72:1682–1700. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Zhou X, Li Y, Xu Y, Lu K, Li P
and Wang X: Inhibition of maternal embryonic leucine zipper kinase
with OTSSP167 displays potent anti-leukemic effects in chronic
lymphocytic leukemia. Oncogene. 37:5520–5533. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cho YS, Kang Y, Kim K, Cha YJ and Cho HS:
The crystal structure of MPK38 in complex with OTSSP167, an orally
administrative MELK selective inhibitor. Biochem Biophys Res
Commun. 447:7–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li G, Yang M, Zuo L and Wang MX: MELK as a
potential target to control cell proliferation in triple-negative
breast cancer MDA-MB-231 cells. Oncol Lett. 15:9934–9940.
2018.PubMed/NCBI
|
|
42
|
Li Y, Li Y, Chen Y, Xie Q, Dong N, Gao Y,
Deng H, Lu C and Wang S: Correction to: MicroRNA-214-3p inhibits
proliferation and cell cycle progression by targeting MELK in
hepatocellular carcinoma and correlates cancer prognosis. Cancer
Cell Int. 18:552018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bollu LR, Shepherd J, Zhao D, Ma Y,
Tahaney W, Speers C, Mazumdar A, Mills GB and Brown PH: Mutant P53
induces MELK expression by release of wild-type P53-dependent
suppression of FOXM1. NPJ Breast Cancer. 6:22020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oliva M, Munoz-Aguirre M, Kim-Hellmuth S,
Wucher V, Gewirtz ADH, Cotter DJ, Parsana P, Kasela S, Balliu B,
Viñuela A, et al: The impact of sex on gene expression across human
tissues. Science. 369:eaba30662020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ren L, Deng B, Saloura V, Park JH and
Nakamura Y: MELK inhibition targets cancer stem cells through
downregulation of SOX2 expression in head and neck cancer cells.
Oncol Rep. 41:2540–2548. 2019.PubMed/NCBI
|
|
46
|
Wang K, Zhu X, Yao Y, Yang M, Zhou F and
Zhu L: Corosolic acid induces cell cycle arrest and cell apoptosis
in human retinoblastoma Y-79 cells via disruption of MELK-FoxM1
signaling. Oncol Rep. 39:2777–2786. 2018.PubMed/NCBI
|
|
47
|
Speers C, Zhao SG, Kothari V, Santola A,
Liu M, Wilder-Romans K, Evans J, Batra N, Bartelink H, Hayes DF, et
al: Maternal embryonic leucine zipper kinase (MELK) as a novel
mediator and biomarker of radioresistance in human breast cancer.
Clin Cancer Res. 22:5864–5875. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tian JH, Mu LJ, Wang MY, Zeng J, Long QZ,
Guan B, Wang W, Jiang YM, Bai XJ and Du YF: BUB1B promotes
proliferation of prostate cancer via transcriptional regulation of
MELK. Anticancer Agents Med Chem. 20:1140–1146. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mierke CT: The matrix environmental and
cell mechanical properties regulate cell migration and contribute
to the invasive phenotype of cancer cells. Rep Prog Phys.
82:0646022019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Seong HA, Manoharan R and Ha H: Zinc
finger protein ZPR9 functions as an activator of AMPK-related
serine/threonine kinase MPK38/MELK involved in ASK1/TGF-beta/p53
signaling pathways. Sci Rep. 7:425022017. View Article : Google Scholar
|
|
51
|
Gu C, Banasavadi-Siddegowda YK, Joshi K,
Nakamura Y, Kurt H, Gupta S and Nakano I: Tumor-specific activation
of the C-JUN/MELK pathway regulates glioma stem cell growth in a
p53-dependent manner. Stem Cells. 31:870–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ren D, Yang Q, Dai Y, Guo W, Du H, Song L
and Peng X: Oncogenic miR-210-3p promotes prostate cancer cell EMT
and bone metastasis via NF-κB signaling pathway. Mol Cancer.
16:1172017. View Article : Google Scholar
|
|
53
|
Jin B, Wang C, Li J, Du X, Ding K and Pan
J: Anthelmintic niclosamide disrupts the interplay of p65 and
FOXM1/β-catenin and eradicates leukemia stem cells in chronic
myelogenous leukemia. Clin Cancer Res. 23:789–803. 2017. View Article : Google Scholar
|
